Akari Therapeutics, Plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CRESSET ASSET MANAGEMENT, LLC | 11/12/2025 | 822.47 K | $830.69 K | 4,367.99% | 251,803.27% |
| PALO ALTO INVESTORS LP | 11/14/2025 | 146.02 K | $147.48 K | 0.00% | 44,706.08% |
| HIGHTOWER ADVISORS, LLC | 11/07/2025 | 79.24 K | $80.03 K | 0.00% | 24,258.55% |
| OMNIA FAMILY WEALTH, LLC | 11/06/2025 | 28.44 K | $28.72 K | -54.63% | 8,707.07% |
| VIRTU FINANCIAL LLC | 11/14/2025 | 22.50 K | $22.00 K | 100.00% | 6,889.12% |
| INDEPENDENT ADVISOR ALLIANCE | 11/04/2025 | 10.89 K | $11.00 K | 100.00% | 3,333.12% |
| NEWEDGE ADVISORS, LLC | 11/17/2025 | 6.80 K | $6.87 K | 0.00% | 2,081.86% |
| ACCENT CAPITAL MANAGEMENT, LLC | 11/12/2025 | 10.00 K | $10.10 K | 0.00% | 3,061.56% |
| TWO SIGMA SECURITIES, LLC | 11/14/2025 | 19.75 K | $19.95 K | 100.00% | 6,047.49% |
| CERITY PARTNERS LLC | 10/22/2025 | 23.64 K | $23.88 K | 0.00% | 7,238.44% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 150 | $152 | 0.00% | 45.92% |
| UBS GROUP AG | 11/13/2025 | 60 | $61 | -97.21% | 18.37% |
| TRUVESTMENTS CAPITAL LLC | 11/14/2025 | 50 | $51 | 0.00% | 15.31% |
| EVERSOURCE WEALTH ADVISORS, LLC | 11/10/2025 | 44 | $44 | -98.99% | 13.47% |
| CORNERSTONE PLANNING GROUP LLC | 11/04/2025 | 7 | $285 | 40.00% | 2.14% |
| MORGAN STANLEY | 11/14/2025 | 3 | $3 | 0.00% | 0.92% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| SABBY MANAGEMENT, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Akari Therapeutics, Plc institutional Ownership - FAQ's
During the previous two years, 21 institutional investors and hedge funds held shares of Akari Therapeutics, Plc. The most heavily invested institutionals were:
Cresset Asset Management, LLC: 822,468
Palo Alto Investors LP: 146,024
HighTower Advisors, LLC: 79,236
Omnia Family Wealth, LLC: 28,440
Cerity Partners LLC: 23,643
Virtu Financial LLC: 22,502
358,222.69% of Akari Therapeutics, Plc stock is owned by institutional investors.
Institutional investors have bought a total of 1.34 M shares in the last 24 months. This purchase volume represents approximately $1.23 M in transactions.